SRA's number for the day: 200
This article was originally published in SRA
More than 200 people expressed an interest in participating in the five advisory groups the European Medicines Agency had set up to help frame agency policy on the proactive publication of drug clinical trial data1.
You may also be interested in...
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.